Bayer and Curevag Two German biotech companies have announced a cooperation agreement for the development and production of the coronavirus vaccine 2019, or COVID-19.
The joint statement by Bayer and Kyawak said: Under the said agreement Kyowag will be able to use Bayer's expertise and reliable infrastructure to develop a vaccine against COVID-19.Kywag has started a third phase of clinical trials of the COVID-19 vaccine. In the middle of December the past More than 35,000 volunteers participated in Europe and Latin America. Kyivak expects the deal will contribute to hundreds of millions of doses of the vaccine to be distributed to locations around the world if it is approved. COVID-19 vaccine Kyivag's vaccine production technology is similar to the Pfizer / BionTech vaccine and the Moderna vaccine approved by the European Medicines Agency yesterday. Vax is still effective for at least three months, even when stored in a regular refrigerator, and Kyo Wak expects a vaccine against COVID-19 this year, with the EU ordering the vaccine. Already 405 million doses
Post :
ทางเข้าjoker